Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8562998 Targeting of antigen presenting cells with immunonanotherapeutics
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
October 9, 2009
Date of Patent
October 22, 2013
Patent Application Number
13123884
Patent Citations Received
US Patent 11801305 Glycotargeting therapeutics
US Patent 11666638 Glycotargeting therapeutics
0
US Patent 11679141 Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
0
US Patent 11744874 Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
8562998
Patent Primary Examiner
Albert Navarro
Find more entities like US Patent 8562998 Targeting of antigen presenting cells with immunonanotherapeutics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE